Prognosis of hospitalized new-onset systolic heart failure in Indo-Asians--a lethal problem

Fahim H Jafary1, Mahesh Kumar, Irfan E Chandna

  • 1Department of Medicine, Section of Cardiology, Aga Khan University Hospital, Karachi, Pakistan.

Journal of Cardiac Failure
|December 11, 2007
PubMed

Insights

Hospitalized systolic heart failure (SHF) patients in Indo-Asians face a poor prognosis. Key predictors of death include low serum sodium, high admission pulse, low systolic blood pressure, and severe mitral regurgitation.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Systolic heart failure (SHF) hospitalization indicates a poor prognosis, especially in Indo-Asians where cardiovascular disease is rising.
  • Limited data exists on SHF outcomes in the Indo-Asian population.

Purpose of the Study:

  • To determine the frequency and predictors of mortality and morbidity in patients admitted with new-onset SHF in Pakistan.

Main Methods:

  • Retrospective review of 196 new-onset SHF patients (ejection fraction <40%) at a tertiary care hospital.
  • Kaplan-Meier survival analysis and Cox regression modeling were used.
  • Exclusion criteria included in-hospital death, life-limiting concomitant disease, and lack of follow-up.

Main Results:

  • The mean age was 61 years, with 77% having prior ischemic heart disease and a mean ejection fraction of 25%.
  • Median follow-up was 379 days. 27.5% died, and 52% experienced death or re-hospitalization for SHF.
  • Independent predictors of death were lower serum sodium, higher admission pulse, lower systolic blood pressure, and severe mitral regurgitation.

Conclusions:

  • Admission for new-onset SHF portends a grave 1-year prognosis for Indo-Asians.
  • Preventing ischemic heart disease is crucial, as developing nations face significant challenges in managing heart failure.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...